New gene therapy reverses symptoms of SYNGAP1-related disorders in mice

Post author:admin
Post published:October 9, 2025
Post category:uncategorized

In an exciting scientific first, researchers at the Allen Institute successfully designed a new gene therapy that reversed symptoms related to SYNGAP1-related disorders (SRD) in mice.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Chemotherapy may reduce HIV-infected T cells

Urgent action needed to close gaps in global pandemic preparedness

Study finds digital CBT for children with anxiety delivers on par with traditional methods, lowers costs

Helpful Links

Subscribe To Us